共 50 条
- [5] Efficacy Outcomes with Relugolix Combination Therapy in Perimenopausal Women with Uterine Fibroids: LIBERTY Studies MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2022, 29 (12): : 1460 - 1460
- [9] Bone Mineral Density Changes over 52 Weeks in Perimenopausal Women with Uterine Fibroids Treated with Relugolix Combination Therapy vs Untreated Cohort MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2022, 29 (12): : 1475 - 1475